Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Norbert Bischofberger
Biotech
Kronos lays off 83% of staff, changes CEO after clinical setback
Kronos is laying off 83% of its staff and ushering in an interim CEO next month as the biotech looks to recover from a recent fumble in the clinic.
Fraiser Kansteiner
Nov 27, 2024 9:56am
Bischofberger's Kronos files for IPO to run pivotal cancer trial
Sep 21, 2020 9:10am
Bischofberger's Kronos buys SYK inhibitors from Gilead
Jul 16, 2020 8:30am
Kronos nabs Celgene research exec as new CMO
Nov 20, 2019 8:28am
